Testosterone, Metformin, or Both, for Hypogonadism in Obese Males

Summary

The purpose of this study is to examine the effects of metformin, testosterone, or both, in males with obesity-related hypogonadism. This study will evaluate changes in insulin resistance, weight loss, body composition, testosterone levels,quality of life and erectile dysfunction. Obese men will receive diet and physical activity counselling, and be randomised to either testosterone, metformin, a combination of both or placebo

Timeline

Start

2013-07-04

Primary completion

2016-07-12

Completion

2016-07-12

Drugs

Indications